Search Results - Gerald Marti

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia by Clifton C. Mo, Ndegwa Njuguna, Paul V. Beum, Margaret A. Lindorfer, Berengere Vire, Elinor Lee, Gerald Marti, Wyndham H Wilson, Ronald P. Taylor, Adrian Wiestner

    Published in Haematologica (2013-08-01)
    Get full text
    Article


  2. 2

    Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia by Qiuyi Zhang, Ying Gao, Ying Gao, Shuchun Lin, Lynn R. Goldin, Yonghong Wang, Holly Stevenson, Daniel C. Edelman, Keith Killian, Gerald Marti, Paul S. Meltzer, Song Xiang, Neil E. Caporaso

    Published in Frontiers in Genetics (2023-01-01)
    Get full text
    Article


  3. 3

    Towards an FDA-cleared basophil activation test by Oral Alpan, Richard L. Wasserman, Theodore Kim, Amy Darter, Atul Shah, Douglas Jones, Donald McNeil, Henry Li, Laura Ispas, Melinda Rathkopf, Elena Perez, Dareen Siri, Maeve O’Connor, Matthew Plassmeyer, Kimberly Romito, Christina Pettibone, Sean O’Reilly, Søren Ulrik Sønder, Gerald Marti

    Published in Frontiers in Allergy (2023-01-01)
    Get full text
    Article


  4. 4

    Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib by Andrew H. Lipsky, Mohammed Z.H. Farooqui, Xin Tian, Sabrina Martyr, Ann M. Cullinane, Khanh Nghiem, Clare Sun, Janet Valdez, Carsten U. Niemann, Sarah E. M. Herman, Nakhle Saba, Susan Soto, Gerald Marti, Gulbu Uzel, Steve M. Holland, Jay N. Lozier, Adrian Wiestner

    Published in Haematologica (2015-12-01)
    Get full text
    Article


Search Tools: